Invention Grant
- Patent Title: Therapeutic uses of compounds which selectively modulate the CB2 receptor
-
Application No.: US13217480Application Date: 2011-08-25
-
Publication No.: US08362039B2Publication Date: 2013-01-29
- Inventor: Alessandra Bartolozzi , Angela Berry , Eugene Richard Hickey , Markus Ostermeier , Doris Riether , Achim Sauer , David Smith Thomson , Lifen Wu , Renee M. Zindell , Patricia Amouzegh , Nigel James Blumire , Stephen Peter East , Monika Ermann , Someina Khor , Innocent Mushi
- Applicant: Alessandra Bartolozzi , Angela Berry , Eugene Richard Hickey , Markus Ostermeier , Doris Riether , Achim Sauer , David Smith Thomson , Lifen Wu , Renee M. Zindell , Patricia Amouzegh , Nigel James Blumire , Stephen Peter East , Monika Ermann , Someina Khor , Innocent Mushi
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Anthony P. Bottino
- Main IPC: A61K31/4525
- IPC: A61K31/4525 ; A61K31/4196 ; A61K31/422 ; A61K31/433
Abstract:
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Public/Granted literature
- US20110312932A1 Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor Public/Granted day:2011-12-22
Information query
IPC分类:
